Transflammation: Innate immune signaling in nuclear reprogramming.

Area of Science:

• Stem cell biology
• Regenerative medicine
• Immunology

Background:

• Somatic cell reprogramming into induced pluripotent stem cells (iPSCs) is a key advance.
• Efficient reprogramming requires innate immune signaling, termed "transflammation."
• Pattern recognition receptors (PRRs) activation alters epigenetic modifiers for open chromatin.

Purpose of the Study:

• To review the role of innate immune signaling in nuclear reprogramming.
• To highlight the involvement of epigenetic plasticity in reprogramming.
• To discuss recent progress in understanding these mechanisms.

Main Methods:

• Review of recent scientific literature on innate immunity and reprogramming.
• Analysis of signaling pathways involving pattern recognition receptors (PRRs), toll-like receptors (TLRs), and RIG-I-like receptors (RLRs).
• Examination of the role of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in reprogramming.

Main Results:

• Activation of PRRs, TLRs, and RLRs triggers signaling cascades (NFκB, IRF-3) that alter epigenetic plasticity.
• Transflammation is involved in both iPSC generation and direct cell lineage reprogramming (transdifferentiation).
• ROS and RNS are identified as mediators of innate immune signaling in nuclear reprogramming.

Conclusions:

• Innate immune signaling is a critical regulator of DNA accessibility and epigenetic plasticity during nuclear reprogramming.
• Understanding transflammation pathways offers new strategies for regenerative medicine and stem cell biology.
• Further research into innate immunity's role can optimize reprogramming protocols.